Vasoactive Intestinal Peptide Receptor, CRTH2, Antagonist Treatment Improves Eosinophil and Mast Cell-Mediated Esophageal Remodeling and Motility Dysfunction in Eosinophilic Esophagitis.
Chandra Sekhar YadavalliSathisha Upparahalli VenkateshaiahAlok K VermaChandrasekhar KatheraPearce S DuncanMichael VaeziRichard J PaulAnil MishraPublished in: Cells (2024)
CRTH2 antagonist treatment is a novel therapeutic strategy for inflammatory cell-induced esophageal motility dysfunction in IL-13-induced chronic experimental EoE.